Home Healthcare Pharmaceuticals Acute Kidney Injury Treatment Market

Acute Kidney Injury Treatment Market Size, Share & Trends Analysis Report By Disease Type (Pre-renal Acute Kidney Injury, Intrinsic Renal Acute Kidney Injury, Post-renal Acute Kidney Injury), By Treatment Type (Renal Replacement Therapy (RRT), Pharmacological Treatment, Supportive & Conservative Treatment) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 19, 2026 | Author: Straits Research Team | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Acute Kidney Injury Treatment Market, By Disease Type 2025-2034 (USD MILLION/ Units)
    1. Pre-renal Acute Kidney Injury
    2. Intrinsic Renal Acute Kidney Injury
    3. Post-renal Acute Kidney Injury
  2. Acute Kidney Injury Treatment Market, By Treatment Type 2025-2034 (USD MILLION/ Units)
    1. Renal Replacement Therapy (RRT)
    2. Pharmacological Treatment
      1. Diuretics
      2. Antibiotics
      3. Vasopressors
      4. Immunosuppressive Agents
      5. Electrolyte-management Drugs
    3. Supportive & Conservative Treatment
  3. Regional Acute Kidney Injury Treatment Market
    1. North America
      1. North America Acute Kidney Injury Treatment Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
      2. North America Acute Kidney Injury Treatment Market By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Renal Replacement Therapy (RRT)
        2. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        3. Supportive & Conservative Treatment
      3. U.S.
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      4. Canada
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
    2. Europe
      1. Europe Acute Kidney Injury Treatment Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
      2. Europe Acute Kidney Injury Treatment Market By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Renal Replacement Therapy (RRT)
        2. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        3. Supportive & Conservative Treatment
      3. U.K.
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      4. Germany
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      5. France
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      6. Spain
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      7. Italy
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      8. Russia
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      9. Nordic
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      10. Benelux
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      11. Rest of Europe
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
    3. APAC
      1. APAC Acute Kidney Injury Treatment Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
      2. APAC Acute Kidney Injury Treatment Market By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Renal Replacement Therapy (RRT)
        2. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        3. Supportive & Conservative Treatment
      3. China
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      4. Korea
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      5. Japan
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      6. India
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      7. Australia
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      8. Taiwan
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      9. South East Asia
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      10. Rest of Asia-Pacific
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
    4. Middle East and Africa
      1. Middle East and Africa Acute Kidney Injury Treatment Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
      2. Middle East and Africa Acute Kidney Injury Treatment Market By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Renal Replacement Therapy (RRT)
        2. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        3. Supportive & Conservative Treatment
      3. UAE
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      4. Turkey
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      5. Saudi Arabia
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      6. South Africa
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      7. Egypt
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      8. Nigeria
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      9. Rest of MEA
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
    5. LATAM
      1. LATAM Acute Kidney Injury Treatment Market By Disease Type 2025-2034 (USD MILLION/ Units)
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
      2. LATAM Acute Kidney Injury Treatment Market By Treatment Type 2025-2034 (USD MILLION/ Units)
        1. Renal Replacement Therapy (RRT)
        2. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        3. Supportive & Conservative Treatment
      3. Brazil
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      4. Mexico
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      5. Argentina
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      6. Chile
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      7. Colombia
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
      8. Rest of LATAM
        1. Pre-renal Acute Kidney Injury
        2. Intrinsic Renal Acute Kidney Injury
        3. Post-renal Acute Kidney Injury
        4. Renal Replacement Therapy (RRT)
        5. Pharmacological Treatment
          1. Diuretics
          2. Antibiotics
          3. Vasopressors
          4. Immunosuppressive Agents
          5. Electrolyte-management Drugs
        6. Supportive & Conservative Treatment
Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com
custom reports
Need a Tailored Report?
80% of our existing clients ask for tailored reports.
Request Customization

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.